TRCT
ACB

Tower Research Capital (TRC)’s Aurora Cannabis ACB Stock Holding History

Tower Research Capital (TRC)’s Portfolio ACB Stock Details ACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353 Sell
108
-1,269
-92% -$4.79K ﹤0.01% 4898
2025
Q4 		$5.81K Sell
1,377
-1,984
-59% -$9.7K ﹤0.01% 4095
2025
Q3 		$20K Sell
3,361
-2,331
-41% -$11.4K ﹤0.01% 3309
2025
Q2 		$24.1K Sell
5,692
-684
-11% -$3.31K ﹤0.01% 3575
2025
Q1 		$28K Buy
6,376
+6,337
+16,249% +$29.9K ﹤0.01% 2668
2024
Q4 		$166 Sell
39
-2,512
-98% -$12.3K ﹤0.01% 5401
2024
Q3 		$15K Sell
2,551
-45
-2% -$267 ﹤0.01% 3428
2024
Q2 		$12K Sell
2,596
-13,000
-83% -$82.3K ﹤0.01% 4054
2024
Q1 		$68.5K Buy
15,596
+15,240
+4,281% +$59K ﹤0.01% 2066
2023
Q4 		$1.7K Sell
356
-20
-5% -$96 ﹤0.01% 5339
2023
Q3 		$2.2K Sell
376
-3,360
-90% -$19.5K ﹤0.01% 5199
2023
Q2 		$20K Buy
3,736
+3,294
+745% +$19.4K ﹤0.01% 3382
2023
Q1 		$3K Buy
442
+397
+882% +$3.47K ﹤0.01% 5163
2022
Q4 		$0 Sell
45
-1,480
-97% -$17.7K ﹤0.01% 5834
2022
Q3 		$19K Sell
1,525
-1,837
-55% -$27K ﹤0.01% 3963
2022
Q2 		$44K Buy
3,362
+1,914
+132% +$47.9K ﹤0.01% 3005
2022
Q1 		$58K Buy
1,448
+26
+2% +$1.1K ﹤0.01% 2606
2021
Q4 		$76K Buy
1,422
+1,229
+637% +$82.7K ﹤0.01% 2423
2021
Q3 		$13K Sell
193
-172
-47% -$12.2K ﹤0.01% 4063
2021
Q2 		$33K Buy
365
+96
+36% +$8.32K ﹤0.01% 3375
2021
Q1 		$25K Buy
269
+231
+608% +$25.8K ﹤0.01% 3699
2020
Q4 		$3K Sell
38
-869
-96% -$63.3K ﹤0.01% 4772
2020
Q3 		$42K Buy
907
+857
+1,714% +$81.4K ﹤0.01% 3605
2020
Q2 		$6K Sell
50
-157
-76% -$17.9K ﹤0.01% 4192
2020
Q1 		$22K Sell
207
-85
-29% -$15.2K ﹤0.01% 1656
2019
Q4 		$76K Buy
292
+120
+70% +$44.7K 0.01% 1101
2019
Q3 		$91K Buy
172
+148
+617% +$110K 0.01% 1407
2019
Q2 		$23K Sell
24
-82
-77% -$82.4K ﹤0.01% 2074
2019
Q1 		$116K Buy
106
+47
+80% +$42K 0.01% 1369
2018
Q4 		$35K Buy
+59
New +$43.5K ﹤0.01% 1519

Other funds holding ACB

TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Tower Research Capital (TRC)'s ACB Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Aurora Cannabis (ACB) stake by 92% in Q1 2026, selling an estimated $4.79K and leaving 108 shares worth $353. The position accounts for ﹤0.01% of the portfolio, ranked #4898.

Tower Research Capital (TRC) first reported a position in ACB in Q4 2018 and has held it in 30 quarters since. The position peaked at $116K in Q1 2019. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Tower Research Capital (TRC) held 108 shares of Aurora Cannabis worth $353 as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,269 Aurora Cannabis shares in Q1 2026, an estimated $4.79K.
  • Aurora Cannabis made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4898 holding.
  • Tower Research Capital (TRC) first reported a position in Aurora Cannabis in Q4 2018 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s Aurora Cannabis position peaked at $116K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.